161 related articles for article (PubMed ID: 10472534)
1. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation.
Seargeant LE; Balachandra K; Mallory C; Dilling LA; Greenberg CR
J Inherit Metab Dis; 1999 Aug; 22(6):740-6. PubMed ID: 10472534
[TBL] [Abstract][Full Text] [Related]
2. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.
Manning NJ; Olpin SE; Pollitt RJ; Webley J
J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149
[TBL] [Abstract][Full Text] [Related]
3. Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes.
Brivet M; Slama A; Saudubray JM; Legrand A; Lemonnier A
Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():154-9. PubMed ID: 7785942
[TBL] [Abstract][Full Text] [Related]
4. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects.
Ventura FV; Costa CG; Struys EA; Ruiter J; Allers P; Ijlst L; Tavares de Almeida I; Duran M; Jakobs C; Wanders RJ
Clin Chim Acta; 1999 Mar; 281(1-2):1-17. PubMed ID: 10217622
[TBL] [Abstract][Full Text] [Related]
5. Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders.
Wanders RJ; Ijlst L; van Elk E; de Klerk JB; Przyrembel H
J Inherit Metab Dis; 1991; 14(3):317-20. PubMed ID: 1770782
[No Abstract] [Full Text] [Related]
6. Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid.
Olpin SE; Manning NJ; Pollitt RJ; Clarke S
J Inherit Metab Dis; 1997 Jul; 20(3):415-9. PubMed ID: 9266370
[No Abstract] [Full Text] [Related]
7. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
9. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
10. The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts.
Olpin SE; Manning NJ; Pollitt RJ; Bonham JR; Downing M; Clark S
Adv Exp Med Biol; 1999; 466():321-5. PubMed ID: 10709659
[No Abstract] [Full Text] [Related]
11. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
[TBL] [Abstract][Full Text] [Related]
12. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
13. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
14. Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.
Renaud DL; Edwards V; Wilson GJ; Tein I
J Inherit Metab Dis; 2002 Nov; 25(7):547-55. PubMed ID: 12638938
[TBL] [Abstract][Full Text] [Related]
15. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial fatty-acid oxidation disorders.
Kompare M; Rizzo WB
Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
[TBL] [Abstract][Full Text] [Related]
18. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects.
Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
J Inherit Metab Dis; 1999 May; 22(3):302-6. PubMed ID: 10384392
[No Abstract] [Full Text] [Related]
19. [Determination of normal acylcarnitine levels in a healthy pediatric population as a diagnostic tool in inherited errors of mitochondrial fatty acid beta-oxidation].
Osorio JH; Pourfarzam M
An Pediatr (Barc); 2007 Dec; 67(6):548-52. PubMed ID: 18053519
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
